Editorial comment: Late potentials and the Brugada syndrome

Journal of the American College of Cardiology

Volumn 39, Issue 12, 2002, Pages 1996-1999

  Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PILSICAINIDE; PROCAINAMIDE; SODIUM CHANNEL;

ADULT; BRUGADA SYNDROME; CASE REPORT; CHROMOSOME 3; ELECTROCARDIOGRAPHY; EPICARDIUM; GENE LOCUS; GENE MUTATION; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE POTENTIAL; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HUMAN; LONG QT SYNDROME; NOTE; PRIORITY JOURNAL; ACTION POTENTIAL; HEART MUSCLE CONDUCTION SYSTEM; PATHOPHYSIOLOGY; SYNDROME;

ACTION POTENTIALS; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HUMANS; SYNDROME; VENTRICULAR FIBRILLATION;

EID: 0037134671     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01887-9     Document Type: Editorial

References (30)

1. Diagnosis and long-term follow-up of Brugada syndrome in patients with idiopathic ventricular fibrillation
2. Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls
3. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation
4. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report
5. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men
6. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome
7. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts
8. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome
9. 3
10. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome
11. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent
12. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes
13. Brugada syndrome and sudden cardiac death in children
14. + channel mutation causing both long-QT and Brugada syndromes
15. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family
16. Recurrent ventricular fibrillation during a febrile illness in a patient with the Brugada syndrome
17. Clinical and molecular heterogeneity in the Brugada syndrome: A novel gene locus on chromosome 3
18. The Brugada syndrome. Diagnostic criteria and cellular mechanisms
19. Electrical heterogeneity in the heart: Physiological, pharmacological and clinical implications
20. The Brugada syndrome: Ionic basis and arrhythmia mechanisms
21. Cellular basis for the electrocardiographic J wave
22. The Brugada syndrome: Clinical, electrophysiological and genetic aspects
23. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome
24. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. The antiarrhythmic effects of 4-aminopyridine
25. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation
26. Brugada
27. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: Insight into the mechanism of Brugada syndrome
28. Epicardial electrogram of the right ventricular outflow tract in patients with Brugada syndrome: Using the epicardial lead
29. The Brugada syndrome: Ionic basis and arrhythmia mechanisms
30. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation